NCT07604883 Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes Status NOT_YET_RECRUITING Phase N/A
NCT07570212 Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders Status RECRUITING Phase NA
NCT07531433 Post-Trial Access to ATH434 for Patients With Multiple System Atrophy Status AVAILABLE Phase N/A
NCT07518810 Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT07476352 Expansion Study of ALT001 in Patients With Multiple System Atrophy Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07392411 Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers Status RECRUITING Phase N/A
NCT07238062 "An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy." Status AVAILABLE Phase N/A
NCT07197866 An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy Status RECRUITING Phase PHASE2
NCT07036939 Efficacy and Safety of Bilateral Cervical Lymphatic-Venous Anastomosis in the Treatment of Multiple System Atrophy Status NOT_YET_RECRUITING Phase NA
NCT06868628 A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA) Status RECRUITING Phase PHASE2
NCT06848231 A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy Status RECRUITING Phase PHASE2
NCT06745011 Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System Status ENROLLING_BY_INVITATION Phase N/A
NCT06738862 [18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients Status COMPLETED Phase N/A
NCT06706622 A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06683365 Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies Status RECRUITING Phase PHASE1
NCT06671938 Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06645626 Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes Status RECRUITING Phase N/A
NCT06607900 hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases Status NOT_YET_RECRUITING Phase PHASE1